Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tagros Chemicals India Pvt Ltd. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is under the review of a distinct examiner, which centralizes the company's current prosecution activity. The matter is located within 1 distinct art unit, providing a specific technical focus for the examination.
KUCKLA, ANNA GRACE is the busiest examiner for the company, currently managing 1 pending office action. Because the portfolio contains a limited number of pending office actions, this examiner oversees the full extent of the company's active responses. The concentration of the current workload within the art unit in the Biotechnology & Pharmaceuticals field streamlines the company's immediate patent office interactions. This focused approach requires a thorough understanding of the examiner's specific technical expectations to ensure the successful advancement of the pending application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KUCKLA, ANNA GRACE | 1 | 53.8% | +51.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681685 | A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS | KUCKLA, ANNA GRACE | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18681685 | A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS | KUCKLA, ANNA GRACE | 1626 | §103 | Final Rejection | — | Pending | Feb 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTagros Chemicals India Pvt Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Anna Grace Kuckla has the most, with 1 of Tagros Chemicals India Pvt Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
